← Back to Analyst Consensus 
INKT Buy
MiNK Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 12, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 21, 2026 | B. Riley Securities | reiterate | Buy → Buy | — | 54% |
| May 18, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 1, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 15, 2025 | HC Wainwright & Co. | upgrade | Neutral → Buy | $35 | 44% |
| Jul 15, 2025 | HC Wainwright & Co. | downgrade | Buy → Neutral | $35 | 44% |
| Jul 14, 2025 | William Blair | downgrade | Outperform → Market Perform | $0 | 48% |
| Mar 18, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $35 | 44% |
| Feb 25, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $35 | 44% |
| Nov 15, 2024 | Baird | maintain | Outperform → Outperform | $4 | 55% |
| Nov 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Oct 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Aug 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| May 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Mar 21, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $9 | 44% |
| Aug 10, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| May 12, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $10 | 44% |
| Apr 19, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $7 | 44% |
| Mar 22, 2023 | Evercore ISI Group | maintain | — → Outperform | $3 | 58% |
| Mar 22, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $7 | 44% |
| Aug 10, 2022 | HC Wainwright & Co. | initiate | — → Buy | $7 | 44% |
| Jan 24, 2022 | B. Riley Securities | maintain | — → Buy | $10 | 54% |
| Nov 9, 2021 | William Blair | initiate | — → Outperform | $0 | 48% |
| Nov 9, 2021 | Evercore ISI Group | initiate | — → Outperform | $30 | 58% |
| Nov 9, 2021 | Baird | initiate | — → Outperform | $26 | 55% |
Price Target Trend
Jun 27, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days